CECOG is proud to announce the foundation of the CECOG Academy as of July 19, 2017. Under the roof of the newly founded "CECOG Academy“, the abundance of all educational activities hitherto conducted by CECOG will be united.Put the CECOG Academy in your pocket now! learn more
|23 – 24|
CECOG is happy to be a Knowledge Partner of the Aspen Healthcare Forum on „Healthcare as an Investment, from Cost to Social Efficiency“ held in Bucharest on October 24, 2017. This conference involving CECOG President Prof. Christoph Zielinski, CECOG partners and friends Dr. Alexander Eniu from Cluj, Dr. Razvan Popescu from Aarau and highest ranking officials from Romania was opened by the President of the Aspen Institute Romania, Mr. Mircea Geoana (see picture).
The CECOG Academy held the 2nd Pancreas Cancer Academy in Prague on November 10 and 11, 2017. The fact that the event drew 141 participants from 28 countries very well illustrated the need in this very disease. CECOG placed emphasis upon the introduction of a dialogue by medical experts, nurses and patient advocates.read more
The CECOG Academy held the First CEE Lung Cancer Academy in Vienna on November 2nd and 3rd , 2017. The event consisted of presentations by Professors, P. Berzinec, T. Ciuleanu, T. Cufer, M. Dediu, G. Galffy, M. Jakopovic, D. Jovanovic, I. Kern, K. Konopa, Z. Mihaylova, W. Olszewski, L. Petruzelka, D. Radosavljevic, A. Ryska and C.Zielinski.read more
CECOG is happy to have produced educational material regarding PD-1 and PD-L1 function and importance for the field of immune oncology. Moreover, teaching slides have been produced referring to the intruiging issue of the blood-brain barrier. All material has been accepted for publication by „ESMO Open - Cancer Horizons“ and can be downloaded from its homepage (esmoopen.bml.com)
With the aim to coordinate clinical trials in oncology according to the standards of Good clinical Practice in the area of Central- and Southeastern Europe, the foundation of CECOG was laid in 1999.
CECOG’s range of activity is not only limited to the conduct of clinical trials but also concentrates on education and the definition of quality standards in regard to the care of patients with malignant diseases.
Univ. Prof. Dr. Christoph Zielinski